Corrigendum to “In Vivo Resistance to Ceftolozane/Tazobactam in Pseudomonas Aeruginosa Arising by AmpC- And Non-AmpC-Mediated Pathways”
Case Reports in Infectious Diseases
doi 10.1155/2019/8314349
Full Text
Open PDFAbstract
Available in full text
Date
September 2, 2019
Authors
Publisher
Hindawi Limited